EN DE
STOCK COMPARISON

Dr.agarwals Eye Hospital Ltd.-$ vs HCA Healthcare: Fair Value & Quality

Both stocks run through our valuation models. Here is how Dr.agarwals Eye Hospital Ltd.-$ (DRAGARWQ) and HCA Healthcare (HCA) compare, as of Oct 5, 2026.

As of Oct 5, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: Dr.agarwals Eye Hospital Ltd.-$ trades at ₹5,181 versus a fair value of ₹2,708 (−47.7%), while HCA Healthcare trades at $427 versus $598 (+40.1%).
Dr.agarwals Eye Hospital Ltd.-$
DRAGARWQ.BSE · INR · Health Care
−47.7%
upside to fair value
overvalued
Price₹5,181
Fair Value₹2,708
Quality54/100
HCA Healthcare
HCA · USD · Health Care
+40.1%
upside to fair value
undervalued
Price$427
Fair Value$598
Quality70/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green is the better side of a row, red the weaker one (for valuation multiples: lower = cheaper). Grey rows are for reference only and are not scored.

betterweakerfor reference, not scored

Dr.agarwals Eye Hospital Ltd.-$HCA Healthcare
Valuation
32.6×P/E (TTM)14.8×
n/aForward P/E (FY2027)13.3×
n/aMedian P/E at FY-end (10 FY, reported earnings)14.0×
5.04×P/S (TTM)1.22×
7.23×P/BNegative equity
16.4×EV/EBITDA8.6×
n/aPEG1.34×
−47.7%Fair value upside+40.1%
0.1%Dividend yield0.7%
₹7.00Dividend per share$3.00
Profitability
22.2%Operating margin15.2%
2.73×EBIT margin trend (5Y)1.12×
25.2%Return on equityNegative equity
9.0%Return on assets12.3%
Growth
22.3%Revenue growth (YoY)8.7%
20.8%Avg. growth/yr (3Y)7.9%
27.5%Avg. growth/yr (5Y)8.0%
+29.4%Value creation/yr+16.7%
Balance & size
8.3×Interest coverage (EBIT/interest)5.3×
0.19×Debt / equityNegative equity
$260MMarket cap$95B
expensiveGrowth qualityhealthy
HCA Healthcare, median P/E at fiscal year-end, 10 fiscal years (2016 to 2025), reported earnings: 14.
Forward P/E: price divided by the analyst consensus for the first fiscal year that has not started yet. The current year carries special items from quarters already reported.

HCA Healthcare leads: 6 to 7 metric wins.

n/a = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Dr.agarwals Eye Hospital Ltd.-$of which business quality 55 · market factors 57 HCA Healthcareof which business quality 67 · market factors 42
ProfitabilityMargins and returns on capital today
65
76
Quality GrowthAre margins and returns improving?
57
61
CashflowEarnings quality: real cash, not paper profit
63
62
Fin. StrengthBalance sheet, leverage, solvency risk
62
41
InvestmentDisciplined investing over empire-building
0
75
Low VolatilityCalm price path (market factor)
86
59
MomentumPrice trend over the last 3–12 months (market factor)
46
35
52W MomentumDistance to the 52-week high (market factor)
43
36
Net IssuanceShare count: buybacks or dilution?
63
100

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyDr.agarwals Eye Hospital Ltd.-$Price ₹5,181HCA HealthcarePrice $427
DCF Models−38.8%below the price₹3,171+44.1%above the price$615
Earnings-Based−43.5%below the price₹2,926−32.2%below the price$289
Dividend Discountn/a−87.4%below the price$53.85
Multiples−44.8%below the price₹2,859+57.7%above the price$673
Asset-Based−90.7%below the price₹480n/a
Growth DCF−50.0%below the price₹2,591+50.7%above the price$643
Economic Profit−72.4%below the price₹1,430−1.9%close to the price$419
Growth Earnings−21.4%below the price₹4,073+18.7%above the price$506
Minimum−90.7%below the price₹480−87.4%below the price$53.85
Maximum−21.4%below the price₹4,073+57.7%above the price$673
Median−44.8%below the price₹2,859+18.7%above the price$506
Geometric mean−59.1%below the price₹2,120−14.2%close to the price$366

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Dr.agarwals Eye Hospital Ltd.-$: 23 of 24 models see the stock below the current price.

HCA Healthcare: 6 of 23 models see the stock below the current price.

Scenario ranges

From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.

Dr.agarwals Eye Hospital Ltd.-$
Price ₹5,181
Fair Value ₹2,708
Bear ₹1,385Bull ₹3,989
HCA Healthcare
Price $427
Fair Value $598
Bear $309Bull $841

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Dr.agarwals Eye Hospital Ltd.-$ · Health Care

Quality score54 · above median
Fair value upside−47.7% · below median

HCA Healthcare · Health Care

Quality score70 · Top 25%
Fair value upside+40.1% · Top 25%

Bottom line

As of Oct 5, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: Dr.agarwals Eye Hospital Ltd.-$ trades at ₹5,181 versus a fair value of ₹2,708 (−47.7%), while HCA Healthcare trades at $427 versus $598 (+40.1%).

HCA Healthcare has the higher quality score (70/100).

Open HCA Healthcare live analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.